Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

McGuire BB et al. – The use of novel molecular biomarkers are being incorporated into clinical practice. The understanding of molecular pathways will lead to tailored treatment to the individual patient.

Related Articles

Chromosomal abnormalities of clear cell renal cell carcinoma: Frequent gain of chromosome 7
Pathology International, 11/19/09    Relevance Score: 89%

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
British Journal of Cancer, 11/20/09    Relevance Score: 84%

Population-based survey of cancer risks in chromosome 3 translocation carriers
Genes, Chromosomes and Cancer, 10/28/09    Relevance Score: 84%

Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
Cancer Research, 10/20/09    Relevance Score: 84%

Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient
Urology, 10/12/09    Relevance Score: 84%

Today in Hematology/Oncology...keeping you current

Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients
Cancer, 11/25/09

The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection
Urologic Oncology: Seminars and Original Investigations, 11/25/09

Juxtaglomerular cell tumor of the kidney--a new classification scheme
Urologic Oncology: Seminars and Original Investigations, 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address